These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


120 related items for PubMed ID: 465886

  • 1. Improved insulin receptor assay: effects of an antidiabetic sulphonylurea on liver membrane insulin receptors from obese hyperglycaemic mice.
    Greenstein BD.
    Br J Pharmacol; 1979 Jun; 66(2):317-22. PubMed ID: 465886
    [Abstract] [Full Text] [Related]

  • 2. Assay of liver membrane insulin receptors in obese, hyperglycaemic (ob/ob) mice: stimulant effect of an oral antidiabetic sulphonylurea drug [proceedings].
    Greenstein BD.
    Br J Pharmacol; 1979 May; 66(1):86P. PubMed ID: 454969
    [No Abstract] [Full Text] [Related]

  • 3. The influence of glimepiride on the binding kinetics of insulin with its skeletal muscle and liver receptors in rats with short term and prolonged hyperglycemia induced by streptozotocin.
    Krauss H, Grzymisławski M, Koźlik J, Sosnowski P, Piatek J, Mikrut K, Maćkowiak P, Paluszak J.
    Med Sci Monit; 2004 Jan; 10(1):BR11-6. PubMed ID: 14704628
    [Abstract] [Full Text] [Related]

  • 4. Insulin binding to liver plasm membranes in the obese hyperglycemic (ob/ob) mouse. Demonstration of a decreased number of functionally normal receptors.
    Soll AH, Kahn CR, Neville DM.
    J Biol Chem; 1975 Jun 25; 250(12):4702-7. PubMed ID: 167002
    [Abstract] [Full Text] [Related]

  • 5. Insulin receptors in the heart muscle. Demonstration of specific binding sites and impairment of insulin binding in the plasma membrane of the obese hyperglycemic mouse.
    Forgue ME, Freychet P.
    Diabetes; 1975 Aug 25; 24(8):715-23. PubMed ID: 169173
    [Abstract] [Full Text] [Related]

  • 6. Different regulation of insulin receptors in intracellular (Golgi) and plasma membranes from livers of obese and lean mice.
    Posner BI, Raquidan D, Josefsberg Z, Bergeron JJ.
    Proc Natl Acad Sci U S A; 1978 Jul 25; 75(7):3302-6. PubMed ID: 210458
    [Abstract] [Full Text] [Related]

  • 7. Effect of fasting and streptozotocin in the obese-hyperglycemic (ob/ob) mouse. Apparent lack of a direct relationship between insulin binding and insulin effects.
    Le Marchand Y, Loten EG, Assimacopoulos-Jeannet F, Forgue ME, Freychet P, Jeanrenaud B.
    Diabetes; 1977 Jun 25; 26(6):582-90. PubMed ID: 140828
    [Abstract] [Full Text] [Related]

  • 8. Degradation of insulin in vitro by liver and epididymal adipose tissue from obese-hyperglycaemic mice.
    Westman S.
    Biochem J; 1968 Jan 25; 106(2):543-7. PubMed ID: 5637359
    [Abstract] [Full Text] [Related]

  • 9. [Insulin receptors-a review (author's transl)].
    Freychet P.
    Diabete Metab; 1975 Mar 25; 1():57-68. PubMed ID: 791721
    [Abstract] [Full Text] [Related]

  • 10. Insulin binding to isolated liver nuclei from obese and lean mice.
    Goidl JA.
    Biochemistry; 1979 Aug 21; 18(17):3674-9. PubMed ID: 476079
    [Abstract] [Full Text] [Related]

  • 11. Extrapancreatic action of the sulphonylurea gliquidone: post-receptor effect on insulin-stimulated glycogen synthesis in rat hepatocytes in primary culture.
    Rinninger F, Kirsch D, Häring HU, Kemmler W.
    Diabetologia; 1984 Jun 21; 26(6):462-5. PubMed ID: 6381193
    [Abstract] [Full Text] [Related]

  • 12. Obese mice have higher insulin receptor levels in the hepatocyte cell nucleus following insulin stimulation in vivo with an oral glucose meal.
    Gletsu NA, Field CJ, Clandinin MT.
    Biochim Biophys Acta; 1999 Aug 30; 1454(3):251-60. PubMed ID: 10452959
    [Abstract] [Full Text] [Related]

  • 13. Extrapancreatic action of sulfonylureas: hypoglycemic effects are not dependent on altered insulin binding or inhibition of transglutaminase.
    Nowak SM, McCaleb ML, Lockwood DH.
    Metabolism; 1983 Apr 30; 32(4):398-402. PubMed ID: 6137754
    [Abstract] [Full Text] [Related]

  • 14. [Insulin receptor interaction with the plasma membranes of liver and muscle cells in a generalized infection in rats].
    Morenkova SA.
    Patol Fiziol Eksp Ter; 1985 Apr 30; (4):43-6. PubMed ID: 3903628
    [No Abstract] [Full Text] [Related]

  • 15. Effect of metformin on hepatocyte insulin receptor binding in normal, streptozotocin diabetic and genetically obese diabetic (ob/ob) mice.
    Lord JM, Atkins TW, Bailey CJ.
    Diabetologia; 1983 Aug 30; 25(2):108-13. PubMed ID: 6354812
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Receptors for polypeptide hormones: direct studies of insulin binding to purified liver plasma membranes.
    Neville DM.
    In Vitro; 1974 Aug 30; 9(6):445-54. PubMed ID: 4377928
    [No Abstract] [Full Text] [Related]

  • 18. Effect of chronic tolbutamide administration on normal and obese-hyperglycemic mice: evidence for post-receptor potentiation of insulin action.
    Poyet C, Feldman JM.
    Res Commun Chem Pathol Pharmacol; 1982 Mar 30; 35(3):355-76. PubMed ID: 7043679
    [Abstract] [Full Text] [Related]

  • 19. Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.
    Mandarino LJ, Gerich JE.
    Diabetes Care; 1984 Mar 30; 7 Suppl 1():89-99. PubMed ID: 6376034
    [Abstract] [Full Text] [Related]

  • 20. Reduced insulin binding to liver plasma membranes in inherently obese diabetic CBA/Ca mice.
    Taberner PV, Connelly DM.
    Biochem Pharmacol; 1991 Mar 01; 41(5):729-33. PubMed ID: 1998527
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.